Assenagon Asset Management’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-120,723	Closed	-$656K	–	1318
2024 Q4	$656K	Sell	120,723 -65,316	-35%	-$399K	﹤0.01%	1162
2024 Q3	$1.34M	Buy	186,039 +18,814	+11%	+$172K	﹤0.01%	1073
2024 Q2	$1.82M	Buy	167,225 +10,632	+7%	+$136K	﹤0.01%	939
2024 Q1	$2.93M	Buy	156,593 +143,075	+1,058%	+$3.3M	0.01%	748
2023 Q4	$293K	Buy	+13,518	New	+$268K	﹤0.01%	1334
2023 Q3	–	Sell	-32,605	Closed	-$1.53M	–	1459
2023 Q2	$1.53M	Sell	32,605 -71,126	-69%	-$3.54M	0.01%	859
2023 Q1	$4.35M	Buy	103,731 +6,897	+7%	+$297K	0.02%	608
2022 Q4	$3.69M	Hold	96,834	–	–	0.01%	613
2022 Q3	$3.79M	Sell	96,834 -77,617	-44%	-$3M	0.01%	545
2022 Q2	$5.63M	Buy	+174,451	New	+$5.85M	0.02%	508
2021 Q4	–	Sell	-32,017	Closed	-$1.42M	–	1544
2021 Q3	$1.42M	Buy	32,017 +8,300	+35%	+$381K	﹤0.01%	813
2021 Q2	$1.35M	Buy	23,717 +7,757	+49%	+$548K	﹤0.01%	831
2021 Q1	$1.2M	Buy	+15,960	New	+$1.31M	﹤0.01%	885